DD201754A5 - Wundbehandlungsmittel in pulverform und verfahren zu seiner herstellung - Google Patents
Wundbehandlungsmittel in pulverform und verfahren zu seiner herstellung Download PDFInfo
- Publication number
- DD201754A5 DD201754A5 DD81233513A DD23351381A DD201754A5 DD 201754 A5 DD201754 A5 DD 201754A5 DD 81233513 A DD81233513 A DD 81233513A DD 23351381 A DD23351381 A DD 23351381A DD 201754 A5 DD201754 A5 DD 201754A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- protein
- treatment agent
- wound
- methacrylic acid
- gel
- Prior art date
Links
- 239000000843 powder Substances 0.000 title claims abstract description 26
- 239000003795 chemical substances by application Substances 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 title claims description 10
- 206010052428 Wound Diseases 0.000 claims abstract description 44
- 208000027418 Wounds and injury Diseases 0.000 claims abstract description 44
- 150000004676 glycans Chemical class 0.000 claims abstract description 16
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 16
- 239000005017 polysaccharide Substances 0.000 claims abstract description 16
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 14
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 14
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims abstract description 13
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical class CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229920001184 polypeptide Polymers 0.000 claims abstract description 11
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 11
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 11
- 239000003431 cross linking reagent Substances 0.000 claims abstract description 8
- 229920000642 polymer Polymers 0.000 claims abstract description 5
- 238000006116 polymerization reaction Methods 0.000 claims abstract description 3
- 239000007864 aqueous solution Substances 0.000 claims abstract 2
- 239000003505 polymerization initiator Substances 0.000 claims abstract 2
- 239000000499 gel Substances 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 239000002245 particle Substances 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 10
- 238000010521 absorption reaction Methods 0.000 claims description 8
- 230000008961 swelling Effects 0.000 claims description 6
- 108010010803 Gelatin Proteins 0.000 claims description 5
- 229920000936 Agarose Polymers 0.000 claims description 4
- 229920000620 organic polymer Polymers 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000008273 gelatin Substances 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 150000001408 amides Chemical class 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 claims 1
- 125000005397 methacrylic acid ester group Chemical group 0.000 claims 1
- 239000000203 mixture Substances 0.000 description 11
- 241000894006 Bacteria Species 0.000 description 9
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000001427 coherent effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 239000003630 growth substance Substances 0.000 description 2
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 108010025899 gelatin film Proteins 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 239000012779 reinforcing material Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0052—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19803036033 DE3036033A1 (de) | 1980-09-24 | 1980-09-24 | Wundbehandlungsmittel in pulverform und verfahren zu seiner herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD201754A5 true DD201754A5 (de) | 1983-08-10 |
Family
ID=6112757
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD81233513A DD201754A5 (de) | 1980-09-24 | 1981-09-23 | Wundbehandlungsmittel in pulverform und verfahren zu seiner herstellung |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4554156A (enExample) |
| EP (1) | EP0048323B1 (enExample) |
| JP (1) | JPS5782313A (enExample) |
| AR (1) | AR227931A1 (enExample) |
| AT (1) | ATE12894T1 (enExample) |
| AU (1) | AU527435B2 (enExample) |
| CA (1) | CA1171787A (enExample) |
| CS (1) | CS236470B2 (enExample) |
| DD (1) | DD201754A5 (enExample) |
| DE (2) | DE3036033A1 (enExample) |
| DK (1) | DK154805C (enExample) |
| ES (1) | ES505512A0 (enExample) |
| FI (1) | FI72654C (enExample) |
| HU (1) | HU186784B (enExample) |
| NO (1) | NO153035C (enExample) |
| PL (1) | PL233144A1 (enExample) |
| ZA (1) | ZA816594B (enExample) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE82511T1 (de) * | 1982-04-22 | 1992-12-15 | Squibb & Sons Inc | Granulate zur verwendung bei der behandlung von wunden. |
| US4652443A (en) * | 1983-06-07 | 1987-03-24 | Japan Atomic Energy Research Institute | Slow-release composite and process for producing the same |
| GB2148901A (en) * | 1983-10-04 | 1985-06-05 | Johnson & Johnson | Protein/polysaccharide complexes |
| DE3574977D1 (de) * | 1984-02-03 | 1990-02-01 | Scott Paper Co | Modifizierte fasern aus cellulose. |
| SE460017B (sv) * | 1984-03-14 | 1989-09-04 | Landstingens Inkopscentral | Bakterieadsorberande komposition i vattenoloeslig form |
| GB8422950D0 (en) * | 1984-09-11 | 1984-10-17 | Warne K J | Hydrogel |
| US5022413A (en) * | 1988-04-21 | 1991-06-11 | Spina Jr Joseph | Intralenticular cataract surgical procedure |
| US5160737A (en) * | 1988-05-03 | 1992-11-03 | Perio Products Ltd. | Liquid polymer composition, and method of use |
| US5438076A (en) * | 1988-05-03 | 1995-08-01 | Perio Products, Ltd. | Liquid polymer composition, and method of use |
| DE3903672C1 (enExample) * | 1989-02-08 | 1990-02-01 | Lohmann Gmbh & Co Kg | |
| US5035890A (en) * | 1989-04-10 | 1991-07-30 | Dow Corning Corporation | Emulsifier-free hand and body lotion |
| US8603511B2 (en) | 1996-08-27 | 2013-12-10 | Baxter International, Inc. | Fragmented polymeric compositions and methods for their use |
| US8303981B2 (en) | 1996-08-27 | 2012-11-06 | Baxter International Inc. | Fragmented polymeric compositions and methods for their use |
| US6066325A (en) | 1996-08-27 | 2000-05-23 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
| US7435425B2 (en) | 2001-07-17 | 2008-10-14 | Baxter International, Inc. | Dry hemostatic compositions and methods for their preparation |
| US6063061A (en) * | 1996-08-27 | 2000-05-16 | Fusion Medical Technologies, Inc. | Fragmented polymeric compositions and methods for their use |
| US7871637B2 (en) | 1996-08-27 | 2011-01-18 | Baxter International Inc. | Dry hemostatic compositions and methods for their preparation |
| US7101862B2 (en) * | 2001-12-31 | 2006-09-05 | Area Laboratories, Llc | Hemostatic compositions and methods for controlling bleeding |
| GB2384187A (en) * | 2002-01-22 | 2003-07-23 | Johnson & Johnson Medical Ltd | Particulate wound dressing |
| EP1491185B1 (en) | 2002-03-14 | 2009-05-27 | Medrx Co., Ltd. | External medicine for wounds |
| US8834864B2 (en) | 2003-06-05 | 2014-09-16 | Baxter International Inc. | Methods for repairing and regenerating human dura mater |
| US7927626B2 (en) * | 2003-08-07 | 2011-04-19 | Ethicon, Inc. | Process of making flowable hemostatic compositions and devices containing such compositions |
| US8252339B2 (en) * | 2006-04-11 | 2012-08-28 | Massachusetts Institute Of Technology | Medical treatment applications of swellable and deformable microspheres |
| JP5231401B2 (ja) | 2006-05-31 | 2013-07-10 | バクスター・インターナショナル・インコーポレイテッド | 脊髄の手術における導かれた細胞内殖及び制御された組織再生の方法 |
| TWI436793B (zh) | 2006-08-02 | 2014-05-11 | Baxter Int | 快速作用之乾密封膠及其使用和製造方法 |
| US8114159B2 (en) | 2006-11-20 | 2012-02-14 | Depuy Spine, Inc. | Anterior spinal vessel protector |
| CN101842122B (zh) | 2007-10-30 | 2013-12-25 | 巴克斯特国际公司 | 再生性生物功能胶原生物基质用于治疗内脏或腔壁缺损的应用 |
| US8678190B2 (en) | 2009-06-30 | 2014-03-25 | Medline Industries, Inc. | Catheter tray, packaging system, instruction insert, and associated methods |
| US8448786B2 (en) * | 2009-06-30 | 2013-05-28 | Medline Industries, Inc. | Catheter tray, packaging system, instruction insert, and associated methods |
| US20100311026A1 (en) | 2009-06-03 | 2010-12-09 | Tomes Jennifer E | Catheter Tray, Packaging System, and Associated Methods |
| US8631935B2 (en) | 2009-06-03 | 2014-01-21 | Medline Industries, Inc. | Catheter tray, packaging system, and associated methods |
| US8642831B2 (en) | 2008-02-29 | 2014-02-04 | Ferrosan Medical Devices A/S | Device for promotion of hemostasis and/or wound healing |
| US9039783B2 (en) | 2009-05-18 | 2015-05-26 | Baxter International, Inc. | Method for the improvement of mesh implant biocompatibility |
| US12458329B2 (en) | 2009-06-03 | 2025-11-04 | Medline Industries Lp | Catheter tray, packaging system, instruction insert, and associated methods |
| PT2442835E (pt) | 2009-06-16 | 2015-03-23 | Baxter Healthcare Sa | Esponja hemostática |
| CA2784432C (en) | 2009-12-16 | 2019-01-15 | Baxter Healthcare S.A. | Hemostatic sponge |
| SA111320355B1 (ar) | 2010-04-07 | 2015-01-08 | Baxter Heathcare S A | إسفنجة لايقاف النزف |
| CA2801120C (en) | 2010-06-01 | 2019-08-20 | Baxter International Inc. | Process for making dry and stable hemostatic compositions |
| CA2801116C (en) | 2010-06-01 | 2019-02-12 | Baxter International Inc. | Process for making dry and stable hemostatic compositions |
| WO2011151386A1 (en) | 2010-06-01 | 2011-12-08 | Baxter International Inc. | Process for making dry and stable hemostatic compositions |
| WO2013053759A2 (en) | 2011-10-11 | 2013-04-18 | Baxter International Inc. | Hemostatic compositions |
| US20130090291A1 (en) | 2011-10-11 | 2013-04-11 | Baxter Healthcare S.A. | Hemostatic compositions |
| TWI548417B (zh) | 2011-10-27 | 2016-09-11 | 巴克斯特國際公司 | 止血組成物 |
| RU2657955C2 (ru) | 2012-03-06 | 2018-06-18 | Ферросан Медикал Дивайсиз А/С | Контейнер под давлением, содержащий гемостатическую пасту |
| AU2013275758B2 (en) | 2012-06-12 | 2015-03-12 | Ferrosan Medical Devices A/S | Dry haemostatic composition |
| RU2700162C2 (ru) | 2013-06-21 | 2019-09-13 | Ферросан Медикал Дивайсиз А/С | Расширенная под вакуумом сухая композиция и шприц для ее сохранения |
| EP3079731B1 (en) | 2013-12-11 | 2018-08-08 | Ferrosan Medical Devices A/S | Dry composition comprising an extrusion enhancer |
| CA2960309A1 (en) | 2014-10-13 | 2016-04-21 | Ferrosan Medical Devices A/S | Dry composition for use in haemostasis and wound healing |
| AU2015371184B2 (en) | 2014-12-24 | 2020-06-25 | Ferrosan Medical Devices A/S | Syringe for retaining and mixing first and second substances |
| CN107771093B (zh) | 2015-07-03 | 2021-06-15 | 弗罗桑医疗设备公司 | 用于混合两种组分和用于在存储条件下保持真空的注射器 |
| KR20210008479A (ko) | 2018-05-09 | 2021-01-22 | 훼로산 메디칼 디바이스 에이/에스 | 지혈 조성물을 제조하는 방법 |
| CN114306242B (zh) * | 2021-12-29 | 2023-04-25 | 广州佰斯伦医疗器械有限公司 | 含生长因子纳米凝胶的脂质体微粒及其制备方法和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3618213A (en) * | 1970-04-27 | 1971-11-09 | Nat Patent Dev Corp | Denture liners |
| SE452109B (sv) * | 1973-01-29 | 1987-11-16 | Pharmacia Ab | Rengoringsmedel for vetskande utvertes sarytor |
| US3963685A (en) * | 1974-05-13 | 1976-06-15 | Abrahams Robert A | Alcohol soluble hydrophilic polymer via aqueous polymerization |
| US4090013A (en) * | 1975-03-07 | 1978-05-16 | National Starch And Chemical Corp. | Absorbent composition of matter |
| DE2725261C2 (de) * | 1977-06-03 | 1986-10-09 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | Transparentes Flüssigkeitsverbandmaterial, seine Herstellung und Verwendung |
-
1980
- 1980-09-24 DE DE19803036033 patent/DE3036033A1/de not_active Withdrawn
-
1981
- 1981-07-21 AT AT81105755T patent/ATE12894T1/de not_active IP Right Cessation
- 1981-07-21 EP EP81105755A patent/EP0048323B1/de not_active Expired
- 1981-07-21 DE DE8181105755T patent/DE3170119D1/de not_active Expired
- 1981-07-31 AR AR286315A patent/AR227931A1/es active
- 1981-09-02 DK DK388781A patent/DK154805C/da not_active IP Right Cessation
- 1981-09-15 ES ES505512A patent/ES505512A0/es active Granted
- 1981-09-16 CS CS816830A patent/CS236470B2/cs unknown
- 1981-09-18 FI FI812920A patent/FI72654C/fi not_active IP Right Cessation
- 1981-09-18 AU AU75487/81A patent/AU527435B2/en not_active Ceased
- 1981-09-21 JP JP56147984A patent/JPS5782313A/ja active Granted
- 1981-09-23 NO NO813236A patent/NO153035C/no unknown
- 1981-09-23 CA CA000386455A patent/CA1171787A/en not_active Expired
- 1981-09-23 PL PL23314481A patent/PL233144A1/xx unknown
- 1981-09-23 ZA ZA816594A patent/ZA816594B/xx unknown
- 1981-09-23 DD DD81233513A patent/DD201754A5/de unknown
- 1981-09-23 HU HU812750A patent/HU186784B/hu unknown
-
1984
- 1984-11-26 US US06/674,366 patent/US4554156A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| PL233144A1 (en) | 1983-01-17 |
| FI72654B (fi) | 1987-03-31 |
| FI812920L (fi) | 1982-03-25 |
| DE3170119D1 (en) | 1985-05-30 |
| NO153035B (no) | 1985-09-30 |
| NO153035C (no) | 1986-01-08 |
| JPS5782313A (en) | 1982-05-22 |
| HU186784B (en) | 1985-09-30 |
| DK154805C (da) | 1989-06-05 |
| DK154805B (da) | 1988-12-27 |
| JPS6134829B2 (enExample) | 1986-08-09 |
| NO813236L (no) | 1982-03-25 |
| ES8301640A1 (es) | 1983-02-01 |
| US4554156A (en) | 1985-11-19 |
| AU527435B2 (en) | 1983-03-03 |
| AR227931A1 (es) | 1982-12-30 |
| CS236470B2 (en) | 1985-05-15 |
| FI72654C (fi) | 1987-07-10 |
| ATE12894T1 (de) | 1985-05-15 |
| DK388781A (da) | 1982-03-25 |
| CA1171787A (en) | 1984-07-31 |
| DE3036033A1 (de) | 1982-05-06 |
| ES505512A0 (es) | 1983-02-01 |
| AU7548781A (en) | 1982-04-01 |
| EP0048323A1 (de) | 1982-03-31 |
| EP0048323B1 (de) | 1985-04-24 |
| ZA816594B (en) | 1982-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0048323B1 (de) | Wundbehandlungsmittel in Pulverform und Verfahren zu seiner Herstellung | |
| DE69326809T2 (de) | Alginatgel | |
| DE2623056C2 (de) | Verfahren zur Herstellung von festen wasserunlöslichen, in Methanol löslichen, hydrophilen Polymeren | |
| DE3305473C2 (de) | Verfahren zur Herstellung wasserunlöslicher, hydrophiler, elastomerer, druckempfindlicher Kleber und deren Verwendung | |
| DE3744289C2 (enExample) | ||
| DE69519734T2 (de) | Gel enthaltender wundverband | |
| DE19646484C2 (de) | Flüssigkeitsabsorbierende Polymere, Verfahren zu deren Herstellung und deren Verwendung | |
| DE2615128A1 (de) | Zwischenpolymeres | |
| DE60109487T2 (de) | Wasserfreier, hydrophiler absorbierender wundverband | |
| DE69020875T2 (de) | Oestrogenhaltiges Gelpräparat. | |
| DE60313626T2 (de) | Antimikrobieller silberhaltiger wundverband f r kontinuierliche freisetzung | |
| DE69817574T2 (de) | Herstellungsmethode für ein faserfreies, poröses material | |
| EP0040378B1 (de) | Mischung für halbstarre medizinische Stützverbände, damit erhaltene medizinische Binde und Verfahren zu deren Herstellung | |
| CH637833A5 (de) | Transparentes fluessigkeitsverbandmaterial, seine herstellung und verwendung. | |
| DE3128815A1 (de) | Polymeres verbundmaterial, seine herstellung und verwendung | |
| DE2933250A1 (de) | Abdeckmaterial | |
| LV10584B (en) | Aqueous-liquid and blood-absorbing powdery reticulated polymers, process for producing the same and their use as absorbents in sanitary articles | |
| LV10782B (en) | Powdery polymers absorbing water solutions and blood, method for producing and application therof in textilen for bodies hygiene | |
| DE3507775A1 (de) | Absorbierendes material sowie verfahren zu seiner herstellung und seine verwendung | |
| DD145062A5 (de) | Transparentes fluessigkeitsverbandsmaterial | |
| WO2009127653A1 (de) | Schnell benetzbares, hydrokolloid enthaltendes material, verfahren zu dessen herstellung sowie dessen verwendung | |
| DE3628482A1 (de) | Verfahren zur herstellung eines harzes mit hohem absorptionsvermoegen | |
| DE2849570A1 (de) | Transparentes fluessigkeitsverbandsmaterial | |
| EP1909858B1 (de) | Hydrogel | |
| DE69508356T2 (de) | Wundverband |